These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 23812841)
1. Tumor necrosis factor-α-mediated suppression of dual-specificity phosphatase 4: crosstalk between NFκB and MAPK regulates endothelial cell survival. Kao DD; Oldebeken SR; Rai A; Lubos E; Leopold JA; Loscalzo J; Handy DE Mol Cell Biochem; 2013 Oct; 382(1-2):153-62. PubMed ID: 23812841 [TBL] [Abstract][Full Text] [Related]
2. Glutathione peroxidase-1 deficiency augments proinflammatory cytokine-induced redox signaling and human endothelial cell activation. Lubos E; Kelly NJ; Oldebeken SR; Leopold JA; Zhang YY; Loscalzo J; Handy DE J Biol Chem; 2011 Oct; 286(41):35407-35417. PubMed ID: 21852236 [TBL] [Abstract][Full Text] [Related]
3. Over-expression of mitogen-activated protein kinase phosphatase-2 enhances adhesion molecule expression and protects against apoptosis in human endothelial cells. Al-Mutairi M; Al-Harthi S; Cadalbert L; Plevin R Br J Pharmacol; 2010 Oct; 161(4):782-98. PubMed ID: 20860659 [TBL] [Abstract][Full Text] [Related]
4. Redox activation of DUSP4 by N-acetylcysteine protects endothelial cells from Cd²⁺-induced apoptosis. Barajas-Espinosa A; Basye A; Jesse E; Yan H; Quan D; Chen CA Free Radic Biol Med; 2014 Sep; 74():188-199. PubMed ID: 24973647 [TBL] [Abstract][Full Text] [Related]
6. Regulation of angiopoietin-1/Tie-2 receptor signaling in endothelial cells by dual-specificity phosphatases 1, 4, and 5. Echavarria R; Hussain SN J Am Heart Assoc; 2013 Dec; 2(6):e000571. PubMed ID: 24308939 [TBL] [Abstract][Full Text] [Related]
7. Mycophenolic acid attenuates the tumour necrosis factor-α-mediated proinflammatory response in endothelial cells by blocking the MAPK/NF-κB and ROS pathways. Olejarz W; Bryk D; Zapolska-Downar D; Małecki M; Stachurska A; Sitkiewicz D Eur J Clin Invest; 2014 Jan; 44(1):54-64. PubMed ID: 24134657 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of dual-specificity phosphatase 4 enhances cell proliferation and invasiveness in colorectal carcinomas. Ichimanda M; Hijiya N; Tsukamoto Y; Uchida T; Nakada C; Akagi T; Etoh T; Iha H; Inomata M; Takekawa M; Moriyama M Cancer Sci; 2018 Jan; 109(1):250-258. PubMed ID: 29150975 [TBL] [Abstract][Full Text] [Related]
9. Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition. Cagnol S; Rivard N Oncogene; 2013 Jan; 32(5):564-76. PubMed ID: 22430215 [TBL] [Abstract][Full Text] [Related]
10. VEGF autoregulates its proliferative and migratory ERK1/2 and p38 cascades by enhancing the expression of DUSP1 and DUSP5 phosphatases in endothelial cells. Bellou S; Hink MA; Bagli E; Panopoulou E; Bastiaens PI; Murphy C; Fotsis T Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1477-89. PubMed ID: 19741200 [TBL] [Abstract][Full Text] [Related]
11. Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance. Balko JM; Cook RS; Vaught DB; Kuba MG; Miller TW; Bhola NE; Sanders ME; Granja-Ingram NM; Smith JJ; Meszoely IM; Salter J; Dowsett M; Stemke-Hale K; González-Angulo AM; Mills GB; Pinto JA; Gómez HL; Arteaga CL Nat Med; 2012 Jul; 18(7):1052-9. PubMed ID: 22683778 [TBL] [Abstract][Full Text] [Related]
12. Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiency. Jung HH; Lee SH; Kim JY; Ahn JS; Park YH; Im YH Sci Rep; 2016 Sep; 6():33035. PubMed ID: 27604655 [TBL] [Abstract][Full Text] [Related]
13. Dual specificity phosphatase (DUSP)-4 is induced by platelet-derived growth factor -BB in an Erk1/2-, STAT3- and p53-dependent manner. Yin R; Eger G; Sarri N; Rorsman C; Heldin CH; Lennartsson J Biochem Biophys Res Commun; 2019 Nov; 519(3):469-474. PubMed ID: 31526568 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of DUSP6 impairs infectious bronchitis virus replication by negatively regulating ERK pathway and promoting apoptosis. Wang H; Liu D; Sun Y; Meng C; Tan L; Song C; Qiu X; Liu W; Ding C; Ying L Vet Res; 2021 Jan; 52(1):7. PubMed ID: 33431056 [TBL] [Abstract][Full Text] [Related]
15. Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion. Mazumdar A; Poage GM; Shepherd J; Tsimelzon A; Hartman ZC; Den Hollander P; Hill J; Zhang Y; Chang J; Hilsenbeck SG; Fuqua S; Kent Osborne C; Mills GB; Brown PH Breast Cancer Res Treat; 2016 Aug; 158(3):441-54. PubMed ID: 27393618 [TBL] [Abstract][Full Text] [Related]
16. DUSP4 is involved in the enhanced proliferation and survival of DUSP4-overexpressing cancer cells. Ratsada P; Hijiya N; Hidano S; Tsukamoto Y; Nakada C; Uchida T; Kobayashi T; Moriyama M Biochem Biophys Res Commun; 2020 Jul; 528(3):586-593. PubMed ID: 32505357 [TBL] [Abstract][Full Text] [Related]
18. Dual-specificity phosphatase 5 acts as an anti-inflammatory regulator by inhibiting the ERK and NF-κB signaling pathways. Seo H; Cho YC; Ju A; Lee S; Park BC; Park SG; Kim JH; Kim K; Cho S Sci Rep; 2017 Dec; 7(1):17348. PubMed ID: 29229953 [TBL] [Abstract][Full Text] [Related]
19. Paeonol suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking p38, ERK and nuclear factor-kappaB signaling pathways. Nizamutdinova IT; Oh HM; Min YN; Park SH; Lee MJ; Kim JS; Yean MH; Kang SS; Kim YS; Chang KC; Kim HJ Int Immunopharmacol; 2007 Mar; 7(3):343-50. PubMed ID: 17276892 [TBL] [Abstract][Full Text] [Related]
20. Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation. Gröschl B; Bettstetter M; Giedl C; Woenckhaus M; Edmonston T; Hofstädter F; Dietmaier W Int J Cancer; 2013 Apr; 132(7):1537-46. PubMed ID: 22965873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]